oleic acid has been researched along with Hepatoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeli, K; Kohen-Avramoglu, R; Qiu, W; Tsai, J | 1 |
| Jin, FY; Kamanna, VS; Kashyap, ML; Sakai, T | 1 |
2 other study(ies) available for oleic acid and Hepatoblastoma
| Article | Year |
|---|---|
MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Topics: Animals; Apolipoprotein B-100; Butadienes; Cell Line, Tumor; Cricetinae; Diacylglycerol O-Acyltransferase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hepatoblastoma; Hepatocytes; Humans; Lipoproteins, VLDL; Liver Neoplasms; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mesocricetus; Nitriles; Oleic Acid; Particle Size; Rats; RNA, Messenger; Signal Transduction; Triglycerides | 2007 |
Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex.
Topics: Albumins; Apolipoprotein A-I; Apolipoprotein A-II; Dose-Response Relationship, Drug; Drug Interactions; Hepatoblastoma; Humans; Liver Neoplasms; Oleic Acid; Probability; RNA, Messenger; Tumor Cells, Cultured | 2000 |